Benchmarking Launch Strategies for First-in-Class Biotech Products
The Race to the Market: A Tale of Two Biotech Pioneers Imagine two biotech companies racing to launch revolutionary therapies aimed at the same rare disease. Both have groundbreaking science, compelling clinical data, and a promising pipeline. Yet, one secures an 80% market share within the first year, while the other struggles to gain traction. …
Benchmarking Launch Strategies for First-in-Class Biotech Products Read More »